Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive

被引:96
作者
Bosga-Bouwer, AG
van Imhoff, GW
Boonstra, R
van der Veen, A
Haralambieva, E
van den Berg, A
de Jong, B
Krause, V
Palmer, MC
Coupland, R
Kluin, PM
van den Berg, E
Poppema, S
机构
[1] Univ Groningen, Med Ctr, Dept Genet, NL-9713 AW Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Hematol, NL-9713 AW Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Dept Pathol & Lab Med, NL-9713 AW Groningen, Netherlands
[4] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
关键词
D O I
10.1182/blood.V101.3.1149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chromosomal translocations involving t(14;18)(q32;q21) and the chromosome 3q27 region are common in B-cell non-Hodgkin lymphoma of germinal center cell origin. Grade 3B follicular lymphoma (FL), consisting almost exclusively of centroblasts, is a distinct subgroup of follicular lymphomas that has more in common clinically with the aggressive diffuse large B-cell lymphomas than with their indolent FL grade 1 and 2 counterparts. We studied the cytogenetic and molecular genetic aberrations by classic cytogenetics, polymerase chain reaction, Southern blot hybridization, and fluorescence in situ hybridization, with special emphasis on t(14;18), affecting bcl-2, and 3q27 rearrangement, affecting bcl-6, in 32 cases of FL grade 3B. Three distinctive subgroups were identified based upon the existence of breakpoint 3q27, a translocation t(14;18), or the absence of both. Group I involved a t(14;18) and no 3q27 aberrations (n = 13); group II was without a t(14;18) and without 3q27 aberrations (n = 9), but had other cytogenetic aberrations; and group III was without a t(14;18) but with aberrations involving 3q27 (n = 10). None of the FL grade 3B cases harbored both a t(14;18) and 3q27 aberra-tion. These results, in particular the finding of a mutual exclusiveness of bcl-2 and bcl-6 rearrangement, indicate at least 3 different pathways of oncogenesis in FL grade 3B. FL grade 3B with bcl-2 rearrangement probably is part of the same entity as the other follicular lymphomas (1, 2, 3A), whereas the cases with 3q27 abnormalities or other unrelated translocations are more closely related to the majority of diffuse large-cell lymphomas of germinal center cell origin. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:1149 / 1154
页数:6
相关论文
共 27 条
  • [1] FOLLICULAR LARGE-CELL LYMPHOMA - INTERMEDIATE OR LOW-GRADE
    BARTLETT, NL
    RIZEQ, M
    DORFMAN, RF
    HALPERN, J
    HORNING, SJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) : 1349 - 1357
  • [2] BASTARD C, 1994, BLOOD, V83, P2423
  • [3] Capello D, 2000, BLOOD, V95, P651
  • [4] BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS
    CATTORETTI, G
    CHANG, CC
    CECHOVA, K
    ZHANG, JD
    YE, BH
    FALINI, B
    LOUIE, DC
    OFFIT, K
    CHAGANTI, RSK
    DALLAFAVERA, R
    [J]. BLOOD, 1995, 86 (01) : 45 - 53
  • [5] Chaganti RSK, 2000, SEMIN HEMATOL, V37, P396
  • [6] Four cases of follicular lymphoma with t(14;18)(q32;q21) and t(3;4)(q27;p13) with LAZ3 (BCL6) rearrangement
    Daudignon, A
    Bisiau, H
    Le Baron, F
    Laï, JL
    Wetterwald, M
    Galiègue-Zouitina, S
    Morel, P
    Duthilleul, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 111 (02) : 157 - 160
  • [7] Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): A new tool for the assessment of minimal residual disease in follicular lymphomas
    Galoin, S
    AlSaati, T
    Schlaifer, D
    Huynh, A
    Attal, M
    Delsol, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (04) : 676 - 684
  • [8] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997
    Harris, NL
    Jaffe, ES
    Diebold, J
    Flandrin, G
    Muller-Hermelink, HK
    Vardiman, J
    Lister, TA
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3835 - 3849
  • [9] HARRIS NL, 1994, BLOOD, V84, P1361
  • [10] HORSMAN DE, 1995, AM J CLIN PATHOL, V103, P472